[1] Tanaka A, Takikawa H, Mochida S,et al.Changing nomenclature for PBC from "Primary Biliary Cirrhosis" to "Primary Biliary Cholangitis".Nihon Shokakibyo Gakkai Zasshi, 2016,113: 1165-1167.
[2] Talwalkar JA,Lindor KD. Primary biliary cirrhosis. Lancet,2003,362: 53-61.
[3] Invernizzi P, Lleo A, Podda M. Interpreting serological tests in diagnosing autoimmune liver diseases. Semin Liver Dis,2007,27: 161-172.
[4] Carey EJ, Ali AH,Lindor KD. Primary biliary cirrhosis. Lancet,2015,386: 1565-1575.
[5] Chalifoux SL, Konyn PG, Choi G,et al. Extrahepatic manifestations of primary biliary cholangitis. Gut and Liver, 2017,11: 771-780.
[6] Floreani A, Franceschet I, Cazzagon N, et al. Extrahepatic autoimmune conditions associated with primary biliary cirrhosis. Clin Rev Allergy Immunol,2015,48: 192-197.
[7] Jacobson DL, Gange SJ, Rose NR, et al. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol,1997,84: 223-243.
[8] 石光英,马晓媛,谢敬东.不同阶段原发性胆汁性肝硬化患者经不同剂量熊去氧胆酸治疗后外周血T淋巴细胞亚群及细胞因子的变化.临床肝胆病杂志,2015,31: 1447-1451.
[9] Pyzik A, Grywalska E, Matyjaszek-Matuszek B,et al. Immune disorders in hashimoto’s thyroiditis: what do we know so far J Immunol Res, 2015, 2015: 979167. |
